Show simple item record

dc.contributor.authorPark, Kyung Soo
dc.contributor.authorShin, Seung Won
dc.contributor.authorJang, Min Su
dc.contributor.authorShin, Woojung
dc.contributor.authorYang, Kisuk
dc.contributor.authorMin, Junhong
dc.contributor.authorCho, Seung-Woo
dc.contributor.authorOh, Byung-Keun
dc.contributor.authorBae, Jong Wook
dc.contributor.authorJung, Sunghwan
dc.contributor.authorChoi, Jeong-Woo
dc.contributor.authorUm, Soong Ho
dc.date.accessioned2019-01-24T15:40:36Z
dc.date.available2019-01-24T15:40:36Z
dc.date.issued2015-12-18
dc.identifier.issn2045-2322
dc.identifier.other18497
dc.identifier.urihttp://hdl.handle.net/10919/86876
dc.description.abstractAccurate cancer diagnosis often requires extraction and purification of genetic materials from cells, and sophisticated instrumentations that follow. Otherwise in order to directly treat the diagnostic materials to cells, multiple steps to optimize dose concentration and treatment time are necessary due to diversity in cellular behaviors. These processes may offer high precision but hinder fast analysis of cancer, especially in clinical situations that need rapid detection and characterization of cancer. Here we present a novel fluorescent tile DNA nanostructure delivered to cancer cytosol by employing nanoparticle technology. Its structural anisotropicity offers easy manipulation for multifunctionalities, enabling the novel DNA nanostructure to detect intracellular cancer RNA markers with high specificity within 30 minutes post treatment, while the nanoparticle property bypasses the requirement of treatment optimization, effectively reducing the complexity of applying the system for cancer diagnosis. Altogether, the system offers a precise and rapid detection of cancer, suggesting the future use in the clinical fields.en_US
dc.description.sponsorshipKorea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3301]; Basic Science Research Programs through the National Research Foundation (NRF) - Ministry of Science ICT and Future Planning [2013R1A1A1058670, 2013R1A1A2016781]; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2013K1A4A3055268]
dc.format.extent8
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.publisherSpringer Nature
dc.rightsCreative Commons Attribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjecttargeted drug-delivery
dc.subjectliving cells
dc.subjecthybridization
dc.subjecttherapy
dc.subjectprobes
dc.titleA Fluorescent Tile DNA Diagnocode System for In Situ Rapid and Selective Diagnosis of Cytosolic RNA Cancer Markersen_US
dc.typeArticle - Refereed
dc.description.notesWe especially thank Mr. Woo Chul Song for his ardent help and discussion. This work was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI14C3301) and by Basic Science Research Programs through the National Research Foundation (NRF) funded by the Ministry of Science ICT and Future Planning (Grant Nos. 2013R1A1A1058670 and 2013R1A1A2016781) and by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (2013K1A4A3055268).
dc.title.serialScientific Reports
dc.identifier.doihttps://doi.org/10.1038/srep18497
dc.identifier.volume5
dc.type.dcmitypeText
dc.identifier.pmid26678430


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International
License: Creative Commons Attribution 4.0 International